Introduction
Adult T-cell leukemia-associated antigen (ATLA) was first detected in 1980 from a cultured cell line (MT-1) which was derived from a patient with adult Tcell leukemia (ATL) (Hinuma et al. 1981) . Subsequently a retrovirus was isolated from patients with ATL (Miyoshi et al. 1981; Yoshida et al. 1982) . This virus was recognized by molecular and biological analysis to be closely related to the human T-cell leukemia virus (HTLV) (Kalyanaraman et al. 1982; Popovic et al. 1982) which had previously been isolated from two patients with cutaneous T-cell lymphoma in America (Poiesz et al. 1980 (Poiesz et al. , 1981 .
Antibodies to ATLA (anti-ATLA) have been in the sera of almost all patients with ATL and also in the sera of healthy individuals (Hinuma et al. 1981 (Hinuma et al. , 1982 . Healthy individuals who are anti-ATLApositive were found to be carriers of ATLV (Miyoshi et al. 1982; Gotoh et al. 1982) : type C retrovirus particles were de-tected in cultures of their peripheral blood lymphocytes.
Recently Okochi et al. reported that ATLV can be transmitted by blood transf ussion (Okochi et al. 1984) , but the route of ATLV transmission in natural settings remains unclear. Whether or not ATLV can be transmitted by exposure to blood or contact with patients is an important question. Samples from 352 healthy individuals in Nango-cho (estimated population : 1,800), a farming and fishing village located about 20 km from Nichinan City, were used as a second control. Free health examinations, announced by distibution of written notices to homes, were offered to the citizens of the village. 535 serum samples were collected from individuals who came to be examined. Out of these, the 352 from healthy individuals 18 to 65 years old were tested for anti-ATLA and used as a second control.
Assay Methods:
Anti-ATLA was tested for by enzymelinked immunosorbent assay (ELISA) (E-0733, Eisai Co., Tokyo, Japan) (Taguchi et al. 1983) . In order to eliminate false positivity, samples which were judged to be positive but had absorbance values less than 0.300 were assayed by the ELISA inhibition test and by indirect immunofluorescence (IF). They were judged to be positive if they were positive by the inhibition test or IF. In the inhibition test, samples were judged to be positive if their absorbance decreased significantly after they were mixed with purified ATLV. MT-1 cells were used for IF (Miyoshi et al. 1980 ).
Statistical
Methods:
• Because the age and sex distribution of the subjects in the three groups differed considerably, indirect standardization was carried out. Prevalence in male inpatients was significantly higher than prevalence in both male hospital employees (p<0.05) and male control subjects (p< 0.05).
Prevalence in female inpatients was significantly higher than prevalence in female hospital employees (p<0.001), and total prevalence in inpatients was significantly higher than total prevalence in hospital employees (p<0.01). Because prevalence in inpatients was significantly higher than prevalence in hospital employees, we compared prevalence in the control subjects with prevalence in each of the five categories of hospital employees (Table 3) . Among five categories of hospital employees, office workers had the highest prevalence and nurses the next highest.
Prevalence in physicians and laboratory technicians was significantly lower than prevalence in the control subjects (p<0.05 for both), and prevalence in physicians was significantly lower than prevalence in both nurses (p< 0.05) and office workers (p<0.05) . Prevalence in laboratory technicians was significantly lower than prevalence in other non-medical personnel (p<0.05).
Nurses were divided into two groups, non-surgical and surgical. Age-specific prevalence of anti-ATLA is shown in Table  4 . No significant difference was seen between the two groups.
Discussion
It has been documented that ATLV carriers cluster in families, and that ATLV can be transmitted from mother to child (ren) and from husband to wife (Ta ima et al.1982) .
Okochi et al. found that ATLV could be transmitted by blood transfusion, presumably by lymphocytes not serum (Okochi et al. 1984) . These findings prompted us to investigate whether ATLV infection was an occupational hazard for hospital employees or not. We did not, however, investigate seroconversions to anti -ATLA -positive. Inpatients of Nichinan Hospital were used as one of two controls. Serum samples were taken from the inpatients one or two days after admission, when it was unlikely that they had been exposed to hospital patients with ATL or to ATLV carriers in the hospital. These inpatients came mainly from Nichinan City and two towns less than 20 km from the city. One of these towns was Nango -cho, healthy inhabitants of which were used as a second control. Six of the inpatients had malignant lymphoma and were positive for anti-ATLA (Kashiwagi et al. 1985) . Prevalence of anti-ATLA was higher among the inpatients than among the healthy inhabitants of Nango-cho, but the difference was insignificant.
Prevalence of anti-ATLA in the employees of Nichinan Hospital was significantly higher than prevalence in the employees of Nobeoka Hospital and those of M iyazaki Hospital. We think that these differences were probably due to geographical differences in prevalence. Such geographical differences have been reported to exist within Kochi prefecture, Japan (Taguchi et al. 1983) . It should also be Anti-ATLA prevalence in inpatients of Nichinan Hospital and anti-ATLA prevalence in control subjects from Nango-cho were both significantly greater than anti-ATLA prevalence in employees of Nichinan Hospital, even though the employees of that hospital had the highest anti-ATLA prevalence among the employees of the four hospitals in the study.
Of the hospital employees, inpatients, and control subjects, inpatients showed the highest anti-ATLA prevalence. Therefore, anti-ATLA prevalence in each of the five categories of hospital employees was compared with the prevalence in the control subjects.
The highest prevalences were noted among office workers and control subjects. Both of these groups had no direct contact with blood or patients. In contrast, prevalence was lowest in physicians, who had direct contact with blood and patients, and in laboratory technicians, who had direct contact with blood. Furthermore, although prevalence in nurses, who had direct contact with blood and patients, was intermediate among the five categories of hospital employees, it was lower than the prevalence in control subjects, and there was no difference in prevalence between non-surgical nurses and surgical nurses. From these data, we cannot directly draw a conclusion that ATLV cannot be transmitted through medical care. However, it seems highly likely that medical personnel may not have as great risk of infection with ATLV in hospital as they do with HBV.
It has been well documented that hepatitis B infection is a major occupational hazard for hospital personnel (Lewis et al. 1973; Pattison et al. 1975; Denes et al. 1978; Janzen et al. 1978 ) and we previously reported that it was so for the same nurses and surgical physicians who were surveyed for presence of anti-ATLA in the present study (Kashiwagi et al. 1985) . Hepatitis B virus, however, is transmitte serum, whe A , et al. (1982) . Antibodies to adult T-cell leukemiavirusassociated antigen (ATLA) in sera from patients with ATL and controls in Japan : A nation-wide sero-epidemiologic study. Int. J. Cancer, 29, 631-635.
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